Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents.
- Submitting institution
-
Institute of Cancer Research: Royal Cancer Hospital (The)
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 235
- Type
- D - Journal article
- DOI
-
10.1016/j.eururo.2013.11.044
- Title of journal
- Eur Urol
- Article number
- -
- First page
- 459
- Volume
- 66
- Issue
- 3
- ISSN
- 1873-7560
- Open access status
- Out of scope for open access requirements
- Month of publication
- September
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
https://www.sciencedirect.com/science/article/pii/S0302283813013080?via%3Dihub#sec0090
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
9
- Research group(s)
-
-
- Citation count
- 108
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
